Pharmaceutical formulations
The invention provides a solid oral dosage form comprising rilpivirine or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtncitabine or a pharmaceutically acceptable salt thereof.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
04.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides a solid oral dosage form comprising rilpivirine or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtncitabine or a pharmaceutically acceptable salt thereof. |
---|---|
Bibliography: | Application Number: AU20160285916 |